Contract HHSO100201500022C
First Light Diagnostics, Inc. · Department Of Health And Human Services · September 29, 2020
First Light Diagnostics, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 29, 2020 for $4.79 million of work in in-vitro diagnostic substance manufacturing. Performance is in Chelmsford, MA. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses cost-plus contract pricing. The most recent modification was on August 12, 2025. If all options are exercised, the contract could reach $41.41 million.
Contract details
- PIID
- HHSO100201500022C
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Chelmsford, MA
- First action
- September 29, 2020
- Latest action
- August 12, 2025
Description
DE-OBLIGATE $15,438.10 AND CLOSEOUT THE CONTRACT IN ITS ENTIRETY.
Modification timeline
-
August 12, 2025Mod P00029 · Close Out$30.21M
-
September 28, 2022Mod P00023 · Other Administrative ActionFIRST LIGHT DIAGNOSTICS: SUPPLEMENTAL FUNDING AND REVISE COR.$29.72M
-
September 27, 2021Mod P00017 · Funding Only ActionANTHRAX ASSAY R&D - RAPID, SENSITIVE AND COST-EFFECTIVE ANTHRAX TEST AND CLINICAL SURGE-TESTING PLATFORM.$28.54M
-
September 30, 2020Mod P00014 · Supplemental Agreement For Work Within ScopeANTHRAX ASSAY R&D - RAPID, SENSITIVE AND COST-EFFECTIVE ANTHRAX TEST AND CLINICAL SURGE-TESTING PLATFORM.$28.47M
-
September 29, 2020Mod P00013 · Exercise An OptionANTHRAX ASSAY R&D - RAPID, SENSITIVE AND COST-EFFECTIVE ANTHRAX TEST AND CLINICAL SURGE-TESTING PLATFORM.$27.88M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSO100201500022C?
Contract HHSO100201500022C is a federal contract awarded to First Light Diagnostics, Inc. by Department Of Health And Human Services on September 29, 2020 for $4.79 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 4 times since the base award.
Who won contract HHSO100201500022C?
First Light Diagnostics, Inc. won contract HHSO100201500022C from Department Of Health And Human Services.
How much is contract HHSO100201500022C worth?
Contract HHSO100201500022C has obligated $4.79 million to date, with a total potential value of $41.41 million if all options are exercised.